Skip to content

Meli Pharm

Active Private limited companyfounded 2022active for 4 yearsHuart Hamoirlaan 164, 1030 SchaerbeekKBO/BCE: BE 0789.989.972

Lifetime

4 annual accounts with figures on one time axis
peak of €153,570 in 2023
€24,190▲ 4.5%
peak of €112,189 in 2023
€15,056▲ 4.8%
peak of €166,293 in 2025
€166,293▲ 10.0%
€58,232▼ 4.5%
Board1 name since 2022
1 director
Documentsfilings and deeds
29-09-202660 days late
2025micro format
Cash from €20,552 to €836

Key points

from the 2025 annual accounts

Equity

€166,293 ▲ 10.0%

Meli Pharm has made a profit in every financial year since 2022.

Turnover

≈ €260,000 estimated

The accounts state no turnover.

Filings

4 annual accounts 5 filings, 4 late
AprilJune31 JulyOctober2022202320242025

The 2023 accounts came in latest, 484 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Meli Pharm has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Meli Pharm. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 25-08-2022
  • founderdeed of 29-08-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0789989972
Incorporation Founding capital of €2,500 · Founded by (fondateurunique) · appointed as sole director · published on 29-08-2022 · Gazette deed
First establishment Huart Hamoirlaan 164, Schaerbeek
All 12 events

Comparable companies

same main activity, similar in size and age
Company
Meli Pharm Schaerbeek €224,525 €24,190 74.1% -
PHARMACIE SAIDI Sint-Gillis (bij-Brussel) €284,436 €25,191 5.4% -
SATILMIS Sint-Gillis (bij-Brussel) €304,962 €28,925 43.0% -
PHARMACIE BARON DE CASTRO Etterbeek €285,240 €23,988 9.8% -
F-88 Bree €170,105 €25,069 13.2% -
BVV Affligem €202,995 €21,939 99.1% -
Pharmacie du Bien-être Brussels €190,415 €24,538 51.5% -

These companies have the same main activity as Meli Pharm: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €170,000 and €305,000, founded between 2019 and 2022.

Official details

Source: KBO
Status
Active since 25-08-2022Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 1 other
Establishment unit
2.334.713.2891030 Schaerbeek, since 25-08-2022
Financial year end
31 December
Peppol
Reachable since 12-12-2025
Company details

Annual accounts 2025

€224,525▲ 5.8%
Filing
Filed on 29-09-2026
Financials

Insights on Meli Pharm

Meli Pharm files the micro format. That format states no turnover. The gross margin fell from €28,031 in 2022 to €24,190 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Meli Pharm

What is the company number of Meli Pharm?
The company number of Meli Pharm is 0789.989.972. The VAT number is the same number with BE in front: BE 0789.989.972.
Where is Meli Pharm based?
The registered office is at Huart Hamoirlaan 164, 1030 Schaerbeek.Company details
What does Meli Pharm do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Meli Pharm?
Meli Pharm is a private limited company (BV).
When was Meli Pharm founded?
Meli Pharm was founded on 25-08-2022.
Is Meli Pharm still active?
Yes, Meli Pharm is an active enterprise in the KBO register.
What is the turnover of Meli Pharm?
The turnover in financial year 2025 is about €260,000. This figure is estimated from the gross margin of €24,190 and 139 comparable companies (NACE 477). It probably lies between €93,000 and €550,000. It is a rough estimate.Financials
Is Meli Pharm profitable?
In financial year 2025, Meli Pharm made a profit of €15,056.
Where can I find the annual accounts of Meli Pharm?
Meli Pharm filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Meli Pharm due?
Meli Pharm must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.